← Back to generic index

Saxagliptin — brands & medicines in Pakistan

Pakistan mein Saxagliptin ke 1 brands available hain. Drug class: DPP-4 Inhibitor / Antidiabetic. Neeche se koi bhi brand select karein aur uses, dosage, side effects aur price dekhein.

Quick Answer

Saxagliptin is a dpp-4 inhibitor / antidiabetic used in Pakistan for Type 2 diabetes mellitus management, Blood glucose control as monotherapy or in combination therapy, Adjunct to diet and exercise for type 2 diabetes. Available as 1 brand. Prescription required. Always confirm dose with a doctor or pharmacist.

What is Saxagliptin?

Saxagliptin is a dpp-4 inhibitor / antidiabetic used in Pakistan for a range of medical conditions. Doctors and pharmacists in Pakistan recognize Saxagliptin under multiple brand names — currently 1 listed on PakVita (1 tablet). The information below is a synthesis from DRAP-registered medicine entries, BNF, and WHO Essential Medicines references.

Common indications

  • Type 2 diabetes mellitus management
  • Blood glucose control as monotherapy or in combination therapy
  • Adjunct to diet and exercise for type 2 diabetes

Indication and dose vary by medical condition, age, weight, and other factors. Always confirm with a qualified doctor or pharmacist before starting.

Typical dosage

5mg once daily (2.5mg once daily in severe kidney impairment)

This is a general adult guidance pattern based on the manufacturer's label for one of the Saxagliptin brands listed below. Children, elderly patients, pregnant women, and people with kidney or liver impairment usually need different dosing — confirm with your doctor.

Side effects

Common (usually mild)

  • Upper respiratory tract infections (cold-like symptoms)
  • Headache
  • Urinary tract infections

Serious — stop and see a doctor

  • Pancreatitis (severe abdominal pain — stop immediately and see a doctor)
  • Severe hypoglycaemia when combined with insulin or sulphonylureas
  • Heart failure exacerbation — use with caution in patients with known heart failure

Important warnings

  • Don't use Saxagliptin Tablet if you are allergic to saxagliptin or any ingredient
  • Not for type 1 diabetes or diabetic ketoacidosis
  • Stop and seek medical help immediately if pancreatitis is suspected

Conditions treated

Saxagliptin brands in Pakistan (1)

Click any brand to see full uses, dosage, side effects, prices, and warnings.

Frequently asked questions

What is Saxagliptin used for in Pakistan?

Saxagliptin is commonly used for Type 2 diabetes mellitus management, Blood glucose control as monotherapy or in combination therapy, Adjunct to diet and exercise for type 2 diabetes. It belongs to the dpp-4 inhibitor / antidiabetic drug class.

What is the typical dosage of Saxagliptin?

Typical adult dosing is described by manufacturers as: "5mg once daily (2.5mg once daily in severe kidney impairment)". Always confirm dose, duration, and timing with a qualified doctor or pharmacist — dose depends on indication, weight, age, kidney/liver function, and other medications.

What are the common side effects of Saxagliptin?

Common side effects include Upper respiratory tract infections (cold-like symptoms), Headache, Urinary tract infections. Most are mild and resolve as the body adjusts. Stop the medicine and contact a doctor if side effects are severe, persistent, or include allergic symptoms (rash, swelling, breathing difficulty).

When should I stop Saxagliptin and see a doctor?

Stop Saxagliptin and seek urgent medical care if you experience: Pancreatitis (severe abdominal pain — stop immediately and see a doctor); Severe hypoglycaemia when combined with insulin or sulphonylureas; Heart failure exacerbation — use with caution in patients with known heart failure. These are serious signs that need immediate attention.

Is Saxagliptin available without a prescription in Pakistan?

Prescription required.

What brands of Saxagliptin are available in Pakistan?

1 brand of Saxagliptin is listed on PakVita: 1 tablet. Browse the brand list below and click any name for prices, dosage, and full information.

Sources

  1. DRAP Registered Drug Products Database — Drug Regulatory Authority of Pakistan
  2. British National Formulary (BNF) — BMJ Group & Pharmaceutical Press
  3. WHO Model List of Essential Medicines, 23rd ed. — World Health Organization